Related Topics News -

     
 Title only   |   Print    Next page > 
     
加科思獲一致行動人士斥近170萬元增持24萬股

2025-07-24T  
加科思獲一致行動人增持85.44萬股

2025-07-21T  
加科思藥業擬斥資最多1億元回購最多7,887萬股

2025-07-14T  
加科思JAB23E73抑制劑完成美國臨床試驗首例患者給藥

2025-07-02T  
加科思KRAS G12C抑制劑獲批上市 將收5,000萬元里程碑付款

2025-05-22T  
加科思發表SHP2抑制劑Sitneprotafib聯用研究數據

2025-05-09T  
加科思一致行動人士權益變動 持股降至25.21%

2025-05-01T  
《業績》加科思全年虧損收窄至1.56億人民幣

2025-03-20T  
加科思戈來雷塞有良好安全性特徵 已向內地提交新藥上市申請

2025-01-07T  
加科思於美國展示治療骨髓纖維化藥物臨床數據

2024-12-09T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.